What is the Best Management Strategy for a 20-year- old Woman With Premature Ovarian Failure? Reporter: R1 魏君卉 Supervisor: VS 蔡永杰 Clin Endocrinol. 2012;77(2):182-186.

Slides:



Advertisements
Similar presentations
Hormonal Changes at 50 Josephine Carlos-Raboca, MD, FPCP,FPSEM
Advertisements

Contraception in the over 40’s
((Hormone replacement therapy))
for Bio-Identical Hormones
HORMONE REPLACEMENT, AN OVERVIEW DR SARAH WHITFIELD.
MENOPAUSE CURRICULUM SLIDE SET. What is menopause? Menopause is a normal, natural event, defined as the final menstrual period (FMP), confirmed after.
Progesterone Hormone By: Lauren Fuller. Progesterone is…. Progesterone is a female hormone. It prepares the uterus to receive and sustain the fertilized.
2009. WHO IS A SURVIVOR? AN INDIVIDUAL IS A SURVIVOR FROM THE TIME OF THEIR DIAGNOSIS THROUGH THE BALANCE OF THEIR LIFE.
Hormone Replacement Therapy Dr Belinda Magnus. Menopause - Background  Vasomotor symptoms affect around 80% women during the menopause – severe in 20%
Feed back control HBS3A. Simple negative feedback systems.
HRT In a nutshell for all the blokes out there. diagnosis  Clinical hx  FSH limited value as levels fluctuate  May be of value in symtomatic women.
IS HRT SAFE? Rosol Hamid Consultant O&G. NO What is safe? Driving Swimming Crossing the street Cycling Riding a motor bike Parachute jumping Flying.
The Gynaecology Clinic Michaelmas term year 2. This session will: Cover definitions of amenorrhoea and oligomenorrhoea Explain the genetic, anatomical.
M ENOPAUSE Phil Thirkell. D EFINE THE MENOPAUSE [2 MARKS ] No menstrual periods for 12 months.
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
MENOPAUSE Dr. Malak Al Hakeem Prof. of Gynaecology & Obstetrics.
Management of menopause OS Tang Department of Obstetrics and Gynaecology University of Hong Kong.
To treat or not to treat? Highly individualized. Debilitating symptoms. Mild symptoms.
Homework Questions on p of the GCSE Workbook Due in monday
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
MENOPAUSE MENOPAUSE. WHAT ? Menopause is a deviation of the ancient Greek words menos ( month) and pauses (ending). menopause is sometimes known as the.
Hormone Replacement Therapy
DBA UK 14 th Anniversary Conference 17 th -19 th May 2013 Hormonal and fertility issues caused by transfusion Dr Scott Akker Consultant Endocrinologist.
Menopause. What is Menopause? The end of a woman’s menstrual cycle.
Basic Reproduction From
Adult Medical-Surgical Nursing Reproductive Health Module: Ovarian Cyst Polycystic Ovary Syndrome.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
WHI Overview of Principal Results Vanessa M. Barnabei, MD, PhD Medical College of Wisconsin Obstetrics and Gynecology.
Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.
M E N O P A U S E King Khalid University Hospital Department of Obstetrics & Gynecology Course 481.
MANAGING THE MENOPAUSE SUMMARY HRT appropriate for moderate to severe symptoms HRT appropriate for moderate to severe symptoms HRT should not be.
How to survive your menopause David Griffiths Consultant Gynaecologist Christine Pearce Consultant Nurse 3 rd Sept 2014.
OVARIAN CANCER RISK FACTORS Studies have found the following risk factors for ovarian cancer:  Family history of cancer: Women who have a mother, daughter,
Family medicine Common problems in Obstetric and Gynaecology.
Secondary Sex Traits. Hormones – Proteins made in the brain and sex organs Hormones – Proteins made in the brain and sex organs.
Osteoporosis. Background ► The problem  Osteoporosis is common  Over 50% of women and 30-45% of men over age 50 have osteopenia/osteoporosis  White.
Hormone replacement therapy: practical considerations Marco Gambacciani and Nick Panay.
MENAPOUSE. Natural Surgical premature RETROSPECTIVE Cessation of menstruation for 12 months In the absence of other physiological or psychological.
Menopausal Hormone Replacement Professor Gordana Prelevic, MD, DSc, FRCP Consultant Endocrinologist Royal Free Hampstead NHS Trust Whittington Health.
Please feel free to chat amongst yourselves until we begin at the top of the hour.
Developing the Quality of Written Communication in Science AQA Core Science Unit B1 B1.2.2.
What does it mean to age? Deterioration over time! This can include; weakness, susceptibility to disease, loss of mobility and agility. The reduced ability.
Biology, Grade 12 SBI4U Female Reproductive System.
KACIP FATIMAH TEA. “Radiate your feminine charm”
Hormonal Contraceptives. 2 A. Hormonal Contraceptives 1.Combined Oral Contraceptive Pills (COCPs) – Contain both estrogen and progesterone 2.Progestin.
Contraception in the over 40s Ruth Adams Clinical Educator Leicester Sexual Health.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Menopause scenarios. Anita 44yrs, 1 daughter age 6, trying to conceive for 2 years. Periods now irregular, every 6-10/52 Says she’s is under ‘pressure’
HORMONE REPLACEMENT THERAPY (HRT) Evidence-based Guidelines Dr Mahdy El- Mazzahy Damietta general Hospital 7 th International Annual Congress “Alexandria”
M E N O P A U S E King Khalid University Hospital Department of Obstetrics & Gynecology Course 482.
Hyperprolactinaemia. Introduction.  Prolactine (PRL) is secreted from the Anterior Hypophisis.  Normal blood level of PRL: IU/L or 12.5 – 25.
The Ins and Outs of Menopause Jennifer Lyman, MD FACOG Gynecologist, Premier Care for Women Northside Hospital Atlanta, Georgia.
Vikram Talaulikar, Melanie Davies & Gerard S Conway
Hormone Replacement Therapy
Contraception in the over 40’s
Diagnosis and clinical manifestation
Managing Menopausal Symptoms after Breast Cancer Rod Baber
Premenstrual syndrome (PMS)
Contraception in the over 40’s
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Menopause Update Dr Fiona Jacklin April 2018
The Menopause What is it? What are the common symptoms?
Osteoporosis Definition
MENOPAUSE & HRT Nicola Stewart 28/02/2018.
GP Education Meeting September 2018
Hormone Replacement Therapy (HRT)
Special Issues of Women’s Health Care and Reproduction
Presentation transcript:

What is the Best Management Strategy for a 20-year- old Woman With Premature Ovarian Failure? Reporter: R1 魏君卉 Supervisor: VS 蔡永杰 Clin Endocrinol. 2012;77(2): © 2012 Blackwell Publishing

Introduction POF * or ovarian insufficiency [1] is a devastating diagnosis. Doctor shopping: – Effect on rate of conception, long-term health,and psychological well-being Prevalence: <30 y/o, 0.1% ; <40 y/o, 1% * Spontaneous premature ovarian failure

S/S: menstrual disturbance or amenorrhoea Menopausal symptoms: – hot flushes and night sweats, – vaginal dryness, – low libido, low energy levels, – sleep disturbance, lack of concentration, – stiffness, skin/hair changes and mood swings intermittent, reflecting the fluctuations in spontaneous ovarian function, and caused by oestrogen withdrawal.

Investigation Confirmation of Diagnosis: – 1) 6-month period of amenorrhoea or oligomenorrhoea – 2) follicle-stimulating hormone (FSH) > 30 IU/l x2 times, taken at least 4 weeks apart. ** FSH is not an ideal diagnostic tool, because: 1)rises only in the later stages of follicle depletion, 2)marked cycle-to-cycle variability 3)poor at predicting reproductive status

**Better marker - anti-Mullerian hormone (AMH): 1)closely follows the reduction in follicle number 2)falls to very low levels prior to menopause  In assessment of amenorrhoea : -> exclude PCOS # -> antral follicle count -> understand the diagnosis AMH + transvagianl ultrasound # PCOS : polycystic ovarian syndrome

There is no obvious cause of POF, and even if causation is established, the management – including fertility options – remains unchanged. Aetilolgy Gene 5% Offer Karyotype : <25 y/o with POF or Turner’s syndrome FMR 1 ( Fragile X) premature testing * Risk of hereditary Antoimmue 30% little value in assessing antiovarian antibodies Family history pules anti-thyroid Ab: 24% of women with POF * FMR 1 ( Fragile X) premature testing : 4~5% of women with POF ; 14% of women with POF with family history

Associated Medical Conditions Thyroid dysfunction: – TFT test* and antibody testing – TFT : repeated every 2–5 years ;even annually if Ab (+) Adrenal insufficiency: – developing Addison's disease – the danger of cortisol deficiency in pregnancy Low bone mineral density (BMD): – DXA of the lumbar spine and hip Vitamin D deficiency * TFT : thyroid function tests

Psychological Support Premature ovarian failure is a very difficult diagnosis to accept. Effect on her sexuality, femininity and self-image – sexual dysfunction and much higher depression rates – Maybe Infertility Usual support network of family can’t work ! Fertility counsellor: egg donation and adoption

Long-term Health Effects Published data on health risks derive largely from cohort studies of women with surgical menopause (bilateral oophorectomy) -> oestrogen deficiency is less extreme than surgical menopause of women with POF -> The health effects may not be as great increased fracture risk due to lower bone density increased cardiovascular disease decreased breast cancer risk

lower bone density increased fracture risk HRT* : oestradiol-based HRT prevent adverse effects of oestrogen deficiency. Form: transdermal patch**, gel, oral pills Add progestogen : for women with ut. Mass -> oestradiol –base HRT + 14 days progesterone Or-> COCP***: synthetic oestrogen with progestogen in a cyclical formulation testosterone replacement : controversial, only has role of women with lack of libido or energy *HRT: Hormone replacement therapy ** bypassing first-pass metabolism, matching the normal premenopausal state, suitable for the women with migraine or with risk factors for venous thromboembolism ***COCP : combined oral contraceptive pill

Other Treatments Selective serotonin reuptake inhibitors: – venlafaxine and clonidine – treat hot flushes in older women – do not relieve other symptoms or provide bone protection. Complementary Therapy: – widely used, but no convincing evidence for their efficacy Lifestyle Factor: – Calcium: 1200mg/day ; GI upset and renal stone – Vit. D: sunscreen

Fertility spontaneous pregnancy rate: 5% – if don’t want be pregnant, contraception is necessary – Good prognosis: short duration of amenorrhoea autoimmune aetiology ovarian activity seen on ultrasound scan very low AMH

But, there is no intervention has been found to improve conception rates: ovarian stimulation FSH suppression the use of steroids in autoimmune Treatment: – IVF with donor oocytes (the younger, the better) – high-dose HRT: for endometrium thickened – Avoid related donor : maybe poor response to ovarian stimulation due to family history

Egg donation: not allowed : Germany carefully regulated: UK & Canada UK, where donors are unpaid and their anonymity is not guaranteed.

Long-term Follow-up Monitoring: – The role of FSH,serum oestradiol and ethinyloestradiol (in OCPs) or oestrone are poor. Duration of Hormone Replacement Therapy: – Till the age of natural menopause (51 years) – long-term use of HRT in physiological doses does not increase the risk of breast cancer or cause other problems

Take home message 1.POF is a devastating disease which has influence on bone density, CVD risk, social role and conception. 2.HRT has benefit for women with POF, and the dose should be titrated with symptoms control and bone density. 3.Life-long survey is needed, including BMD and the function of endocrine.

Thanks for your attention~